Gergő Dorottya, Garmaa Gantsetseg, Tóth-Mészáros Andrea, To Uyen Nguyen Do, Fehérvári Péter, Harnos Andrea, Hegyi Péter, Nagy Rita, Bánvölgyi András, Ványolós Attila, Csupor Dezső
Department of Pharmacognosy, Semmelweis University, 1085 Budapest, Hungary.
Centre for Translational Medicine, Semmelweis University, 1085 Budapest, Hungary.
J Clin Med. 2025 Jul 17;14(14):5069. doi: 10.3390/jcm14145069.
: Nausea and vomiting frequently occur during postoperative recovery, chemotherapy, and pregnancy. While peppermint oil is traditionally used to relieve these symptoms, its efficacy remains uncertain. This systematic review and meta-analysis evaluates the efficacy of peppermint oil inhalation for postoperative (PONV), chemotherapy-induced (CINV), and pregnancy-related nausea and vomiting (NVP). : Following PRISMA guidelines, we searched five databases (Scopus, Embase, the Cochrane Central Register of Controlled Trials, MEDLINE, and Web of Science) in November 2022, with an update in December 2024. Randomised controlled trials were included, comparing peppermint oil inhalation to a control in patients with PONV, CINV, and NVP. Separate meta-analyses were conducted for each patient group using R, focusing on the severity of the nausea and vomiting. : Nineteen RCTs were included. In three PONV studies, peppermint oil inhalation was associated with a reduction in nausea 2 to 6 h after the intervention (MD: -0.60 points, 95% confidence interval (CI): -0.77 to -0.44, = 0.004). In three NVP studies, daily peppermint oil treatment was linked to lower symptom severity at 48 h (MD: -0.51, 95% CI: -0.78 to -0.24, = 0.015) and 96 h (MD: -0.68, 95% CI: -1.09 to -0.27, = 0.019). In three CINV studies, peppermint oil inhalation appeared to reduce symptoms at all time points, with the most notable reduction at 48 h (MD: -2.23, 95% CI: -3.13 to -1.34, < 0.001) and 72 h (MD: -2.41, 95% CI: -3.96 to -0.86, = 0.010). : Peppermint oil inhalation may be a promising complementary therapy for reducing nausea and vomiting in postoperative, chemotherapy, and pregnancy settings.
恶心和呕吐在术后恢复、化疗及孕期经常出现。虽然传统上使用薄荷油来缓解这些症状,但其疗效仍不确定。本系统评价和荟萃分析评估了吸入薄荷油对术后恶心呕吐(PONV)、化疗引起的恶心呕吐(CINV)及妊娠相关恶心呕吐(NVP)的疗效。按照PRISMA指南,我们于2022年11月检索了五个数据库(Scopus、Embase、Cochrane对照试验中央注册库、MEDLINE和科学网),并于2024年12月进行了更新。纳入了随机对照试验,比较了吸入薄荷油与对照组对PONV、CINV和NVP患者的疗效。使用R软件对每个患者组进行单独的荟萃分析,重点关注恶心和呕吐的严重程度。纳入了19项随机对照试验。在三项PONV研究中,吸入薄荷油与干预后2至6小时恶心减轻相关(MD:-0.60分,95%置信区间(CI):-0.77至-0.44,P = 0.004)。在三项NVP研究中,每日使用薄荷油治疗与48小时(MD:-0.51,95%CI:-0.78至-0.24,P = 0.015)和96小时(MD:-0.68,95%CI:-1.09至-0.27,P = 0.019)时症状严重程度较低有关。在三项CINV研究中,吸入薄荷油似乎在所有时间点都能减轻症状,在48小时(MD:-2.23,95%CI:-3.13至-1.34,P < 0.001)和72小时(MD:-2.41,95%CI:-3.96至-0.86,P = 0.010)时减轻最为显著。吸入薄荷油可能是一种有前景的辅助疗法,用于减轻术后、化疗及孕期的恶心和呕吐。